Jim Cavuoto, Publisher of Neurotech Reports and conference host, gave an excellent talk that covered some of the major events in the neurodevice sector over the past year. These included:
- St. Jude purchase last week of Advanced Neurostimulation (ANSI)
- Cyberonics' VNS approval for Treatment Resistant Depression (first foray of neurodevices into psychiatric illness)
- Rechargeable SCS Onslaught (SCS = spinal cord stimulation)
- Medtronic buying binge - Transneuronix and IGN
- Boston Scientific - Aspect Medical deal (Aspect has a brain state analyzer to help understand what set of part of the patient population might respond to different types of treatments)
- ANSI DBS Entry
- Otto Bock purchase of NeuroDan
- FDA Approvals (Cyberonics VNS for TRD), Medtronic Activa HUD for OCD, Medtronic ONSTIM IDE for ONS (Occipital Nerve Stimulation for Migraine), BSC/Medtronic/ANSI Rechargeable SCS
Thanks for signing in,
.
Now you can comment. (sign out)
(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)